1. Home
  2. FOUR vs ADMA Comparison

FOUR vs ADMA Comparison

Compare FOUR & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shift4 Payments Inc.

FOUR

Shift4 Payments Inc.

HOLD

Current Price

$59.21

Market Cap

4.7B

ML Signal

HOLD

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$16.90

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOUR
ADMA
Founded
1999
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.7B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
FOUR
ADMA
Price
$59.21
$16.90
Analyst Decision
Buy
Strong Buy
Analyst Count
23
2
Target Price
$95.87
$28.50
AVG Volume (30 Days)
1.9M
2.3M
Earning Date
02-17-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
14.66
205.35
EPS
2.15
0.86
Revenue
$3,878,400,000.00
$488,559,000.00
Revenue This Year
$28.63
$22.13
Revenue Next Year
$24.60
$24.15
P/E Ratio
$27.65
$19.87
Revenue Growth
23.16
27.63
52 Week Low
$58.44
$13.50
52 Week High
$127.50
$25.67

Technical Indicators

Market Signals
Indicator
FOUR
ADMA
Relative Strength Index (RSI) 33.71 41.32
Support Level $61.80 $16.62
Resistance Level $66.92 $17.79
Average True Range (ATR) 2.62 0.77
MACD -0.48 -0.13
Stochastic Oscillator 7.80 33.49

Price Performance

Historical Comparison
FOUR
ADMA

About FOUR Shift4 Payments Inc.

Shift4 Payments Inc is provider of integrated payment processing and technology solutions. The company offers software providers a single integration to an end-to-end payments offering, a powerful gateway and a robust suite of technology solutions (including cloud enablement, business intelligence, analytics, and mobile) to enhance the value of their software suites and simplify payment acceptance. The company derives maximum revenue from United States.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: